Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.07 USD | -4.66% | -0.97% | -25.93% |
Chart calendar Leap Therapeutics, Inc.
Upcoming events on Leap Therapeutics, Inc.
Past events on Leap Therapeutics, Inc.
2024-03-18 07:00 am | Q4 2023 Earnings Release |
2024-01-23 08:30 am | Business Update Call |
2024-01-20 06:30 am | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number: 104 |
2024-01-17 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium |
2024-01-10 04:30 pm | JPMorgan Healthcare Conference |
2023-11-28 08:00 am | Piper Sandler Healthcare Conference |
2023-11-13 07:00 am | Q3 2023 Earnings Release |
2023-09-13 03:10 pm | Baird Global Healthcare Conference |
2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
2023-08-14 07:00 am | Q2 2023 Earnings Release |
2023-06-15 | Annual General Meeting |
2023-06-05 12:30 pm | American Society of Clinical Oncology Conference - Abstract Number: 4027 |
2023-05-15 07:00 am | Q1 2023 Earnings Release |
2023-03-24 07:00 am | Q4 2022 Earnings Release |
2023-03-15 | Extraordinary Shareholders Meeting |
2023-01-18 01:30 pm | B. Riley Securities Oncology Conference |
2023-01-17 09:00 am | Acquisition of Flame Biosciences, Inc. by Leap Therapeutics, Inc. Call |
2022-11-29 04:00 pm | Piper Sandler Healthcare Conference |
2022-11-14 07:00 am | Q3 2022 Earnings Release |
2022-11-10 09:00 am | Society for Immunotherapy of Cancer Meeting - Abstract Number: 553 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 1,50 1,70 -11.76% | 1,50 1,52 -1.63% | 0,00 1,20 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -33,5 -32,7 -2.32% | -28,5 -30,7 6.95% | -41,4 -43,0 3.62% | -56,8 -55,9 -1.62% | -87,0 -87,9 0.95% | -71,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -32,9 -32,5 -1.23% | -27,5 -35,4 22.37% | -40,6 -41,1 1.07% | -54,4 -55,2 1.33% | -81,4 -83,8 2.86% | -69,8 |
Net income Million USD | Released Forecast Spread | -33,3 -32,5 -2.33% | -37,6 -40,5 7.15% | -40,6 -41,1 1.13% | -54,6 -55,2 1.07% | -81,4 -83,8 2.86% | -69,8 |
EPS USD | Released Forecast Spread | -14,7 -14,2 -3.52% | -6,30 -6,40 1.56% | -4,70 -4,92 4.47% | -4,80 -4,88 1.64% | -3,98 -3,50 -13.71% | -2,25 |
Announcement Date | 16/03/20 | 12/03/21 | 11/03/22 | 24/03/23 | 18/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,38 0,30 23.03% | 0,00 0,15 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 1,20 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -10,5 -12,0 12.9% | -10,6 -11,3 5.59% | -16,9 -11,0 -53.35% | -15,3 -13,3 -15.03% | -13,9 -13,0 -6.93% | -42,7 -14,4 -196.56% | -14,7 -14,2 -3.11% | -14,8 -15,2 2.1% | -14,8 -15,7 5.31% | -16,1 | -17,2 | -18,3 | -19,6 | -18,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,8 -11,3 3.9% | -10,4 -11,0 5.77% | -17,0 -10,9 -56.83% | -15,1 -13,2 -14.29% | -12,0 -12,8 6.87% | -41,9 -13,4 -211.67% | -13,4 -13,6 1.74% | -13,7 -14,2 3.37% | -12,5 -14,9 16.13% | -15,7 | -16,8 | -18,0 | -19,2 | -17,2 |
Net income Million USD | Released Forecast Spread | -10,8 -11,3 4.11% | -10,4 -11,0 5.77% | -17,0 -10,9 -56.83% | -15,1 -13,2 -14.29% | -12,1 -12,8 5.72% | -41,9 -13,4 -211.67% | -13,4 -13,6 1.74% | -13,7 -14,2 3.37% | -12,5 -14,9 16.13% | -15,7 | -16,8 | -18,0 | -19,2 | -17,2 |
EPS USD | Released Forecast Spread | -0,80 -1,10 27.27% | -0,90 -1,00 10% | -1,50 -0,96 -56.25% | -1,30 -1,18 -10.17% | -1,00 -1,10 9.09% | -3,20 -0,86 -272.09% | -0,91 -0,90 -1.56% | -0,51 -0,58 11.76% | -0,20 -0,56 63.96% | -0,59 | -0,62 | -0,62 | -0,49 | -0,40 |
Announcement Date | 11/03/22 | 13/05/22 | 12/08/22 | 14/11/22 | 24/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 18/03/24 | - | - | - | - | - |
Past sector events for Leap Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LPTX Stock
- Calendar Leap Therapeutics, Inc.